A Phase 3 Randomized Double-blind Trial of Maintenance with Niraparib versus Placebo in Patients with Platinum Sensitive Ovarian Cancer.
Study sites
- AZ Groeninge, Kortrijk
- CHR Citadelle, Liège
- CHU Sart Tilman, Liège
- UZ Antwerpen, Edegem
- UZ Leuven, Leuven
